[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Immunology](https://durgical.com/en/immunology/) › [Cytokines and molecules](https://durgical.com/en/immunology/areas/molecules/) › Cytokine storm: CRS, HLH, sepsis and severe COVID-19

# Cytokine storm: CRS, HLH, sepsis and severe COVID-19

- Topic

In a cytokine storm the immune system releases so many inflammatory signals that the response itself, not the trigger, causes shock and organ failure.

Updated Nov 15, 2026

## Key points

- Cytokine storm = fever + hypotension + capillary leak + organ failure from excess IL-6/IL-1/TNF/IFN-γ.
- CAR-T CRS → [tocilizumab](https://durgical.com/en/pharmacology/tocilizumab/) (anti-IL-6 receptor).
- HLH: cytopenias, splenomegaly, very high ferritin, [low fibrinogen](https://durgical.com/en/haematology/fibrinogen-disorders-too-little-faulty-or-used-up/), [high triglycerides](https://durgical.com/en/endocrinology/high-triglycerides-and-the-pancreatitis-threshold/).
- MAS is HLH in a rheumatic disease; IL-1 blockade helps.
- Superantigens activate many T cells at once.

On this page

- The basics Key points
- What it is
- How to think about it
- Key facts
- Step by step
- Main settings of cytokine storm
- Common traps
- Elsewhere in DurgiPedia

- Clinical Clinical notes

- Study Test yourself

- Connections Connections

## What it is

Cytokine storm is a life-threatening state of uncontrolled, systemic release of inflammatory cytokines such as IL-6, IL-1, TNF and IFN-γ. It shows as high fever, low [blood pressure](https://durgical.com/en/physiology/systolic-diastolic-mean-and-pulse-pressure/), capillary leak, cytopenias and multiorgan dysfunction. It occurs after CAR-T and T-cell-engaging therapies (cytokine release syndrome), in [haemophagocytic lymphohistiocytosis](https://durgical.com/en/haematology/haemophagocytic-lymphohistiocytosis/), in severe infections including sepsis and [COVID-19](https://durgical.com/en/conditions/covid-19/), and with superantigens. Treatment targets both the trigger and the dominant cytokine.

## How to think about it

A storm is a feed-forward loop without a brake: activated T cells make IFN-γ, which activates macrophages, which make IL-6, IL-1 and TNF, which activate more cells. Every setting has a different starter (CAR-T, EBV, a superantigen) but the same loop, so treatment removes the starter and cuts the loudest cytokine.

## Key facts

- Ferritin rises very high in HLH and macrophage activation syndrome, higher than in most other inflammatory states.
- Soluble CD25 ([IL-2](https://durgical.com/en/pharmacology/aldesleukin/) receptor α) is a marker of T-cell activation used in HLH work-up.
- [Corticosteroids](https://durgical.com/en/pharmacology/classes/corticosteroids/) broadly suppress cytokine production but increase infection risk.

## Step by step

- A trigger activates many cells at once: CAR-T or bispecific-engaged T cells, a virus, a superantigen, or killer cells that cannot finish their job.
- Activated T and NK cells release IFN-γ; macrophages respond with IL-6, IL-1 and TNF.
- These cytokines activate yet more macrophages and T cells: the loop feeds itself.
- Endothelium is activated and leaky: fever, hypotension, oedema and hypoxaemia.
- Macrophages engulf blood cells and the [liver](https://durgical.com/en/anatomy/liver/) is injured: cytopenias, very high ferritin, low fibrinogen.
- Without treatment the result is multiorgan failure; blocking the dominant cytokine and removing the trigger breaks the loop.

## Main settings of cytokine storm

| Setting | Trigger | Dominant mediators | Clues | Targeted approach |
| --- | --- | --- | --- | --- |
| Cytokine release syndrome | [CAR-T cells](https://durgical.com/en/biochemistry/topics/gene-therapy/), [bispecific T-cell engagers](https://durgical.com/en/pharmacology/classes/bispecific-t-cell-engagers/) | IL-6, IFN-γ | Fever and hypotension days after infusion; may come with neurotoxicity | Tocilizumab, [glucocorticoids](https://durgical.com/en/physiology/actions-of-cortisol/) |
| Haemophagocytic lymphohistiocytosis (HLH) | Inherited cytotoxicity defects; EBV, cancer, autoimmune disease | IFN-γ, IL-18 | Fever, splenomegaly, cytopenias, very high ferritin, low fibrinogen | [Etoposide](https://durgical.com/en/pharmacology/etoposide/) -based therapy, anti-IFN-γ, transplant for genetic forms |
| Macrophage activation syndrome | Still disease, systemic juvenile arthritis, lupus | IL-1, IL-18, IFN-γ | Falling ESR with rising ferritin in a known rheumatic patient | IL-1 blockade, glucocorticoids |
| [Sepsis](https://durgical.com/en/conditions/sepsis-and-septic-shock/) | Bacterial infection | TNF, IL-1, IL-6 | Organ dysfunction from infection; later immune paralysis | Antibiotics and source control; supportive care |
| [Severe COVID-19](https://durgical.com/en/conditions/covid-19/) | [SARS-CoV-2](https://durgical.com/en/microbiology/sars-cov-2/) | IL-6, IL-1, type I interferon imbalance | Hypoxaemia, high CRP and D-dimer, lymphopenia | [Dexamethasone](https://durgical.com/en/pharmacology/dexamethasone/), tocilizumab or JAK inhibitor |
| Toxic shock syndrome | Staphylococcal or streptococcal superantigens | IL-2, TNF, IFN-γ from many T cells | Fever, rash, desquamation, shock | Remove source, antibiotics, supportive care |

## Clinical notes

- Cytokine release syndrome is graded by fever, hypotension and [oxygen](https://durgical.com/en/pharmacology/oxygen/) needs; neurotoxicity ([ICANS](https://durgical.com/en/haematology/antibodies-bispecifics-and-car-t-cells-how-they-work-and-their-emergencies/)) is assessed separately.
- In a febrile patient with cytopenias and splenomegaly, very high ferritin should prompt consideration of HLH.
- Dexamethasone reduced mortality in hospitalised COVID-19 patients who needed oxygen.

## Common traps

- **Cytokine release syndrome after CAR-T means the therapy failed**: CRS reflects T-cell activation and often accompanies a working therapy.
- **Tocilizumab blocks IL-6 itself**: it blocks the IL-6 receptor, so serum IL-6 can rise after it is given.
- **A falling ESR in a sick rheumatic patient means improvement**: in macrophage activation syndrome fibrinogen is consumed, so ESR falls while ferritin soars.
- **HLH is always inherited**: secondary HLH from EBV, cancer or autoimmune disease is more common in adults than the familial form.
- **Glucocorticoids are harmless add-ons in every storm**: they help in CRS and severe COVID-19 but increase infection risk, so sepsis care relies on source control.

## Test yourself

Think of the answer, then tap the question to see it.

## Five days after CAR-T infusion a patient has fever and hypotension. Which cytokine pathway is targeted first, and how?

IL-6, with tocilizumab blocking the IL-6 receptor; glucocorticoids are added for severe or neurologic toxicity.

## A febrile patient has splenomegaly, pancytopenia, very high ferritin and low fibrinogen. What should you suspect and why the fibrinogen?

HLH: activated macrophages and [liver injury](https://durgical.com/en/conditions/liver-injury/) consume and fail to make fibrinogen, while IFN-γ-driven macrophages raise ferritin.

## Why does toxic shock syndrome cause a storm without any prior immunity?

Superantigens bind MHC class II and the TCR Vβ outside the antigen groove, activating a large fraction of all T cells at once.

[Add to my cards (3)](https://durgical.app/estudiar/?add=/en/immunology/cytokine-storm-crs-hlh-sepsis-and-severe-covid-19/)

## Elsewhere in DurgiPedia

- [Histiocytic disorders: HLH and Langerhans cell histiocytosis](https://durgical.com/en/general-pathology/histiocytic-disorders-hlh-and-langerhans-cell-histiocytosis/)
- [Systemic effects of inflammation: fever, acute-phase proteins, leukocytosis, sepsis](https://durgical.com/en/general-pathology/systemic-effects-of-inflammation-fever-acute-phase-proteins-leukocytosis-sepsis/)

## Connections

## Related 9

- [Cytokines: the table to know](https://durgical.com/en/immunology/cytokines-the-table-to-know/)
- [Interleukin-6](https://durgical.com/en/immunology/interleukin-6/)
- [Interleukin-1](https://durgical.com/en/immunology/interleukin-1/)
- [TNF-α](https://durgical.com/en/immunology/tnf/)
- [Interferon-γ](https://durgical.com/en/immunology/interferon/)
- [Defects in lymphocyte killing: familial HLH and XLP](https://durgical.com/en/immunology/defects-in-lymphocyte-killing-familial-hlh-and-xlp/)
- [Cancer immunotherapy: checkpoint inhibitors, CAR-T and vaccines](https://durgical.com/en/immunology/cancer-immunotherapy-checkpoint-inhibitors-car-t-and-vaccines/)
- [COVID-19: the immune response, immunopathology and vaccines](https://durgical.com/en/immunology/covid-19-the-immune-response-immunopathology-and-vaccines/)
- [T-cell activation: two signals and superantigens](https://durgical.com/en/immunology/t-cell-activation-two-signals-and-superantigens/)

## Related conditions 5

- [Sepsis and septic shock](https://durgical.com/en/conditions/sepsis-and-septic-shock/)
- [COVID-19](https://durgical.com/en/conditions/covid-19/)
- [Adult-onset Still disease](https://durgical.com/en/conditions/adult-onset-still-disease/)
- [Juvenile idiopathic arthritis](https://durgical.com/en/conditions/juvenile-idiopathic-arthritis/)
- [Infectious mononucleosis](https://durgical.com/en/conditions/infectious-mononucleosis/)

## Microorganisms 4

- [SARS-CoV-2](https://durgical.com/en/microbiology/sars-cov-2/)
- [Staphylococcus aureus](https://durgical.com/en/microbiology/staphylococcus-aureus/)
- [Streptococcus pyogenes](https://durgical.com/en/microbiology/streptococcus-pyogenes/)
- [Epstein–Barr virus](https://durgical.com/en/microbiology/epstein-barr-virus/)

## In Pharmacology 3

- [Tocilizumab](https://durgical.com/en/pharmacology/tocilizumab/)
- [Anakinra](https://durgical.com/en/pharmacology/anakinra/)
- [JAK inhibitors](https://durgical.com/en/pharmacology/classes/jak-inhibitors/)

[← All of immunology](https://durgical.com/en/immunology/)

Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.

Sources: [CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers](https://www.cancer.gov/about-cancer/treatment/research/car-t-cells) (National Cancer Institute (NIH), 2024); [Familial hemophagocytic lymphohistiocytosis](https://medlineplus.gov/genetics/condition/familial-hemophagocytic-lymphohistiocytosis/) (MedlinePlus Genetics, US National Library of Medicine, 2024); [COVID-19 (Coronavirus Disease 2019)](https://medlineplus.gov/covid19coronavirusdisease2019.html) (MedlinePlus, US National Library of Medicine, 2024).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/immunology/cytokine-storm-crs-hlh-sepsis-and-severe-covid-19/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/immunology/cytokine-storm-crs-hlh-sepsis-and-severe-covid-19/
